Physical Activity in Cancer Patients in an Oncology Day Clinic - Implementing a Person-centered Program Led by Nurses
Launched by ST.GALLEN UNIVERSITY OF APPLIED SCIENCES · May 22, 2025
Trial Information
Current as of July 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called OncoMoveNurse, is exploring how a nurse-led program can encourage physical activity among cancer patients receiving treatment at an outpatient clinic. Research shows that staying active can help reduce side effects and improve overall well-being for people undergoing cancer treatments, but many patients struggle to maintain their activity levels. The goal of this study is to see if the OncoMoveNurse program is practical and beneficial in helping patients become more active while they receive care.
To participate, patients need to be at least 18 years old, have a cancer diagnosis, and have undergone at least three treatments at the clinic. The study will gather feedback from around 50 patients over about 15 months, examining how their activity levels change and how they feel overall. Participants can expect to take part in a supportive program that includes various activities, safety guidelines, and resources to help them stay engaged. All information collected will be kept private and secure, following strict data protection laws. This study aims to improve the way we promote physical activity in cancer care and could lead to better outcomes for patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. diagnosis of cancer,
- • 2. at least three treatments at the oncology outpatient clinic in Münsterlingen during the study period,
- • 3. aged ≥18 years, and
- • 4. sufficient knowledge of German.
- Exclusion Criteria:
- • pregnancy
About St.Gallen University Of Applied Sciences
St. Gallen University of Applied Sciences is a leading institution dedicated to advancing education and research in applied sciences, with a strong emphasis on innovation and practical solutions in healthcare. The university actively engages in clinical trials to explore and validate new methodologies and technologies that enhance patient care and outcomes. Through collaboration with industry partners and healthcare professionals, St. Gallen University of Applied Sciences aims to translate research findings into real-world applications, contributing to the advancement of medical science and the improvement of health systems.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Antje Koller, PhD
Principal Investigator
Eastern Switzerland University of Applied Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported